Repeated Mazindol and Methamphetamine Administration Produces Cross-Sensitization to Stereotyped Behavior Induced by these Agents in Rats

Acta Medica Okayama

Volumn 52, Issue 3, 1998, Pages 169-171

  Kawakami, Yasuhiro ^a   Suemaru, Katsuya ^a   Araki, Hiroaki ^a   Kawasaki, Hiromu ^a   Gomita, Yutaka ^a   Tanizaki, Yoshiro ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cross sensitization; Mazindol; Methamphetamine; Stereotyped behavior

Indexed keywords

ANOREXIGENIC AGENT; DOPAMINE UPTAKE INHIBITOR; MAZINDOL; METHAMPHETAMINE;

ANIMAL; ARTICLE; DRUG ADMINISTRATION; DRUG EFFECT; DRUG INTERACTION; DRUG SCREENING; MALE; RAT; STEREOTYPY; WISTAR RAT;

ANIMALS; APPETITE DEPRESSANTS; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; MALE; MAZINDOL; METHAMPHETAMINE; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR;

EID: 0032092942     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Engstrom RG, Kelly LA and Gogerty JH: The effects of 5-hydroxy-5-(4′-chlorophenyl)-2, 3-dihydro-5H-imidazo (2, 1-a) isoindol (mazindol, SaH 42 548) on the metabolism of brain norepinephrine. Arch Int Pharmacodyn Ther (1975) 214, 308-321.
2. Zambotti F, Carruba MO, Barzaghi F, Vicentini L, Groppetti A and Mantegazza P: Behavioural effects of a new non-phenylethylamine anorexigenic agents: Mazindol. Eur J Pharmacol (1976) 36, 405-412.
3. Kawakami Y, Suemaru K, Kawasaki H and Gomita Y: Behavioral changes induced by repeated administration of mazindol, an anorexiant, in rats. Jpn J Psychopharmacol (1996) 16, 139-143.
4. Hirabayashi M and Alan MR: Enhancing effect of methamphetamine on ambulatory activity produced by repeated administration in mice. Pharmacol Biochem Behav (1981) 15, 925-932.
5. Angrist BM, Shopsin B and Gershon S: The comparative psychotomimetic effects of steroisomers of amphetamine. Nature (1971) 234, 152-153.
6. Nishikawa T, Magata N, Takashima M and Toru M: Behavioral sensitization and hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Eur J Pharmacol (1983) 88, 195-203.